The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

dc.contributor.authorAkbulut, Hakan
dc.contributor.authorOcal, Muge
dc.contributor.authorSonugur, Fatma Gizem
dc.contributor.authorAbgarmi, Samira Abdi
dc.contributor.authorBabahan, Cansu
dc.contributor.authorAkay, Busra
dc.contributor.authorArslan, Ulku Yalcintas
dc.date.accessioned2024-02-23T14:29:10Z
dc.date.available2024-02-23T14:29:10Z
dc.date.issued2018
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.1200/JCO.2018.36.15_suppl.e15553
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2018.36.15_suppl.e15553
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14584
dc.identifier.volume36en_US
dc.identifier.wosWOS:000442916005036en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleThe trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.en_US
dc.typeConference Objecten_US

Dosyalar